A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)
Public ClinicalTrials.gov record NCT06597344. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Open-label, Single-arm Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study will be conducted to evaluate the clinical symptom improvement and safety of oral gepotidacin for treatment of uncomplicated UTI (acute cystitis) in adolescent and adult female participants.
Study identification
- NCT ID
- NCT06597344
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 97 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2, 2024 (Actual)
- Primary completion
- Mar 10, 2025 (Actual)
- Completion
- Mar 10, 2025 (Actual)
- Last update posted
- Feb 11, 2026
2024 – 2025
United States locations
- U.S. sites
- 22
- U.S. states
- 8
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Modesto | California | 95350-5365 | — |
| GSK Investigational Site | Pasadena | California | 91101-2453 | — |
| GSK Investigational Site | San Diego | California | 92120-5259 | — |
| GSK Investigational Site | Valencia | California | 91355 | — |
| GSK Investigational Site | Miami | Florida | 33135 | — |
| GSK Investigational Site | Ormond Beach | Florida | 32174-6302 | — |
| GSK Investigational Site | Palm Springs | Florida | 33406-7671 | — |
| GSK Investigational Site | Palm Springs | Florida | 33461 | — |
| GSK Investigational Site | Plant City | Florida | 33563-4202 | — |
| GSK Investigational Site | Sweetwater | Florida | 33172-2741 | — |
| GSK Investigational Site | West Palm Beach | Florida | 33409-3401 | — |
| GSK Investigational Site | West New York | New Jersey | 07093-2622 | — |
| GSK Investigational Site | New York | New York | 10016-7313 | — |
| GSK Investigational Site | Dayton | Ohio | 45424 | — |
| GSK Investigational Site | Forney | Texas | 75126-4174 | — |
| GSK Investigational Site | Houston | Texas | 77036 | — |
| GSK Investigational Site | Houston | Texas | 77087 | — |
| GSK Investigational Site | Kingwood | Texas | 26537 | — |
| GSK Investigational Site | Mesquite | Texas | 75149 | — |
| GSK Investigational Site | Missouri City | Texas | 77459-4756 | — |
| GSK Investigational Site | Bountiful | Utah | 84010-4943 | — |
| GSK Investigational Site | Morgantown | West Virginia | 26501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06597344, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 11, 2026 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06597344 live on ClinicalTrials.gov.